The Efficacy and Safety of HLX208 in Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation
Clinical trial NCT05127759 · UNKNOWN
Trial details
- NCT number
- NCT05127759
- Sponsor
- Shanghai Henlius Biotech
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-23
- Primary completion
- 2024-01-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.